Page last updated: 2024-10-29

indomethacin and Anhidrotic Ectodermal Dysplasia

indomethacin has been researched along with Anhidrotic Ectodermal Dysplasia in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldyne, ME1
Williams, ML1

Other Studies

1 other study available for indomethacin and Anhidrotic Ectodermal Dysplasia

ArticleYear
CHILD syndrome. Phenotypic dichotomy in eicosanoid metabolism and proliferative rates among cultured dermal fibroblasts.
    The Journal of clinical investigation, 1989, Volume: 84, Issue:1

    Topics: Abnormalities, Multiple; Dinoprostone; DNA; Ectodermal Dysplasia; Fibroblasts; Humans; Indomethacin;

1989